- Home
- TGI vs LGND Comparison
TGI vs LGND Comparison
Compare TGI & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGI
- LGND
- Stock Information
- Founded
- TGI 1993
- LGND 1987
- Country
- TGI United States
- LGND United States
- Employees
- TGI N/A
- LGND N/A
- Industry
- TGI Aerospace
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- TGI Industrials
- LGND Health Care
- Exchange
- TGI Nasdaq
- LGND Nasdaq
- Market Cap
- TGI 2.0B
- LGND 2.0B
- IPO Year
- TGI 1996
- LGND 1992
- Fundamental
- Price
- TGI $24.70
- LGND $104.97
- Analyst Decision
- TGI Hold
- LGND Strong Buy
- Analyst Count
- TGI 8
- LGND 7
- Target Price
- TGI $20.63
- LGND $144.67
- AVG Volume (30 Days)
- TGI 2.4M
- LGND 127.9K
- Earning Date
- TGI 05-22-2025
- LGND 05-06-2025
- Dividend Yield
- TGI N/A
- LGND N/A
- EPS Growth
- TGI N/A
- LGND N/A
- EPS
- TGI 7.25
- LGND N/A
- Revenue
- TGI $1,242,654,000.00
- LGND $167,133,000.00
- Revenue This Year
- TGI $3.60
- LGND $16.47
- Revenue Next Year
- TGI $10.85
- LGND $19.44
- P/E Ratio
- TGI $144.89
- LGND N/A
- Revenue Growth
- TGI 7.23
- LGND 27.28
- 52 Week Low
- TGI $11.01
- LGND $67.72
- 52 Week High
- TGI $25.55
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- TGI 43.71
- LGND 47.85
- Support Level
- TGI $24.23
- LGND $100.30
- Resistance Level
- TGI $25.00
- LGND $107.62
- Average True Range (ATR)
- TGI 0.34
- LGND 6.00
- MACD
- TGI -0.08
- LGND 0.59
- Stochastic Oscillator
- TGI 39.29
- LGND 74.98
About TGI Triumph Group Inc.
Triumph Group Inc designs and manufactures a broad portfolio of aerostructures, aircraft components, and systems for the aviation industry. It serves a customer base of players in the commercial, business, and military markets. The company operates under two operating segments: Systems and Support, which derives key revenue and designs, develops, and supports proprietary components; and Interiors, which supplies commercial and regional manufacturers with aircraft interior systems.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.